clovis – HedgeChatter

Rayno Biopharma Stocks at ASCO: ARRY, CLVS, RXDX

Biotech Indices Can’t Break Through Triple Top
IBB at $365, XBI at $239
Red and green day
Biotech stocks were mixed today with the major indices holding the flat line. However with all of the clinical data coming out of ASCO (American Society for Clinical Oncology) 2015 in Chicago, IL many “immuno-oncology” stocks were movers.
First look at Rayno Biopharmaceutical Portfolio stocks:
Our big mover […]

Stifel Talks 5 Biotech Stocks – ARIAD Pharmaceuticals, Inc …

Related ARIAMorning Market GainersBenzinga’s Top #PreMarket GainersThe Vetr community has downgraded $ARIA to 3-Stars(Vetr)Related CLVSGoldman Sachs Previews ASCO Cancer Conference With Amgen, Celgene And Clovis OncologyBenzinga’s Volume MoversStifel analyst Brian Klein published abstracts Thursday from the 2015 ASCO annual meeting.Klein’s following comments along with current ratings were intended to provide investors with “meaningful insight into ongoing clinical activities for various […]